Skip to content

Crossover Comparison Study - Verification of the Effect of Okra Pickles in Preventing Elevated Blood Glucose Levels (Pickles First Effect)

Crossover Comparison Study - Verification of the Effect of Okra Pickles in Preventing Elevated Blood Glucose Levels (Pickles First Effect) - Crossover Comparison Study - Verification of the Effect of Okra Pickles in Preventing Elevated Blood Glucose Levels (Pickles First Effect)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057493
Enrollment
20
Registered
2025-04-03
Start date
2025-04-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Ingesting 150g of rice followed by 60g of pickled okra 5 minutes later Ingesting 60g of pickled okra followed by 150g of rice 5 minutes later

Sponsors

Macromill, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Men and women aged 20 to 50 at the time of consent 2)Those who feel that they consume too little vegetables in their daily lives 3)Subjects who have fully understood the purpose of participating in this clinical study and have given their voluntary written consent

Exclusion criteria

Exclusion criteria: 1)with following diseases Type2 diabetes,glucose tolerance,dyslipidemia,hypertension(exclude grade1 hypertension),hyperuricemia,gout,myocardial infarction,angina pectoris,cerebral thrombosis,transient ischemic attack,fatty liver(nonalcoholic fatty liver),menstrual abnormalities,pregnancy complications(pregnant with hypertension,gestational diabetes),sleep apnea syndrome,obesity hypoventilation syndrome, osteoarthritis(knee,hip),spondylosis,low back pain,obesity-related kidney disease,other chronic diseases(digestive,cardiac,liver,kidney,neurological,stroke,rheumatism,etc.) 2)who history or complications of malignancy 3)who family history of diabetes or glucose tolerance 4)who treat by drug,device,rehabilitation,etc.,regardless of seasonal,chronic,sudden illness at screening 5)who medical history in 3months 6)who BMI is less than 18.5 and over 25kg/m2 7)who surgery in past 8)with food allergy or sensitive or specific constitutions 9)who on drug treat 10)who experienced feel unwell or worse physical condition by blood drawn past 11)who donated 200mL within 4weeks or component donated within 2weeks prior to intake 12)Women who donated 400mL within 16weeks prior to intake 13)Men who donated 400mL within 12weeks prior to intake 14)who taking Over-the-counter drug,supplements,or foods for specified health uses 15)who wish to pregnant during the study 16)who breastfeed,pregnant and plan to pregnant 17)judged by the principal to require treat for mental illness 18)who smoke or alcohol excessively 19)who nightwork,cannot take regular off,irregular lifestyles 20)who likely to experience major changes in living environment(home,work,etc.)during the study(moving,job transfer,longtravel,etc.)or in their eating or exercise habits 21)who currently participating other study,participated within 4weeks of WEB screening,or scheduled to participate other study during the study 22)who cannot comply management matters during the study 23)judged inappropriate for the study by principal

Design outcomes

Primary

MeasureTime frame
1)Postprandial blood glucose level 2)Blood insulin levels 3)HbA1c

Secondary

MeasureTime frame
1)Serum electrolyte concentrations (Na, K, Cl-) 2)BMI

Countries

Japan

Contacts

Public ContactTomohiro Hoshino

Macromill, Inc. Clinical Research Unit, Life Science Division

t_hoshino@macromill.com03-6716-0700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026